IKARIA® TO PRESENT AT 2011 BIO INVESTOR FORUM
Hampton, NJ, October 18, 2011 – Ikaria, Inc., a critical care company focused on developing and
commercializing innovative therapies designed to address the significant needs of critically ill
patients in the hospital and ICU settings, today announced that its Chairman and CEO, Daniel
Tassé, will present at the 2011 Biotechnology Industry Organization (BIO) Investor Forum. Mr.
Tassé's presentation will be given on Tuesday, October 25, 2011 from 11:30 to 11:55 a.m. PDT in
the Pacific Heights Room at the Palace Hotel in San Francisco, CA.
About Ikaria, Inc.
Ikaria, Inc. is a critical care company focused on developing and commercializing innovative
therapies designed to address the significant needs of critically ill patients in the hospital and ICU
settings. Ikaria's therapies are designed to meet the unique and complex medical needs of these
critically ill patients. The Company’s lead product is INOMAX® (nitric oxide) for inhalation, the only
FDA-approved drug for the treatment of hypoxic respiratory failure associated with pulmonary
hypertension in term and near-term infants. It is offered through the INOMAX therapy package, an
all-inclusive offering of drug product, drug-delivery system, on-site training and 24/7/365 technical
assistance and support. Ikaria, alone or through partners, also markets the INOMAX therapy
package in Puerto Rico, Canada, Australia, Mexico and Japan. The Company is pursuing a
number of new indications for INOMAX. Ikaria’s late-stage pipeline also is comprised of
LUCASSIN® (terlipressin), a potential treatment for hepatorenal syndrome Type 1, as well as IK-
5001, a potential treatment for preventing cardiac remodeling and subsequent congestive heart
failure following acute myocardial infarction. The Company also has a number of investigational
compounds in development. Ikaria is headquartered in Hampton, NJ, with research facilities in
Seattle, WA and Madison, WI, and manufacturing facilities in Port Allen, LA and Madison, WI.
Please visit www.ikaria.com.
###